Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial

NCT06319248 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06319248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06319248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
May 14, 2024
Completion date
July 30, 2029
Enrollment
308 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

low blood pressure, sepsis